- World rank, all time
- #28,181 of 42,892
- Rank in Switzerland
- #283 of 429
- Research works
- 186 ◆ 1% vs 2013–17
- Citations
- 5.1k 27.4 per fractional work
- Top-10% rate
- 7.2% record average 16.5%
- Open access
- 47% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.8×
- Immunology and Microbiology 5.3×
- Medicine 1.6×
- Materials Science 1.2×
- Engineering 0.8×
- Earth and Planetary Sciences 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Health Professions 0.7×
- Environmental Science 0.5×
- Arts and Humanities 0.5×
- Agricultural and Biological Sciences 0.3×
- Economics, Econometrics and Finance 0.3×
- Social Sciences 0.1×
Who are the top researchers at Basilea Pharmaceutica (Switzerland)?
Ranked on the composite score, Heidi A. Lane, Mark E. Jones and Malcolm G. P. Page lead among researchers whose main affiliation is Basilea Pharmaceutica (Switzerland).
- 1 Heidi A. Lane Switzerland · #342,814 worldwide 129 citations · 32 works
- 2 Mark E. Jones Switzerland · #565,101 worldwide 35 citations · 17 works
- 3 Malcolm G. P. Page Switzerland · #687,364 worldwide 111 citations · 23 works
- 4 Paul M.J. McSheehy Switzerland · #1,005,889 worldwide 10 citations · 17 works
- 5 Marc Engelhardt Switzerland · #1,374,699 worldwide 7 citations · 19 works
Which keywords describe research at Basilea Pharmaceutica (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Cancer, Virulence Factors, Metabolism, Healthcare-Associated Infections, Cancer Therapy and Clinical Management.
- Mechanical Properties
- Microorganism Identification
- Warburg Effect
- HIF-1
- Tumor Microenvironment
- Fibroblast Growth Factor
- Critically Ill Patients
- Obesity
- Geopolymer
- Cell Division
- Signaling
- MRSA
- Clinical Management
- Healthcare-Associated Infections
- Virulence Factors
- Antimicrobial Resistance
- Epidemiology
- Cancer
- Metabolism
- Cancer Therapy
- CO2 Sequestration
- Staphylococcus aureus
- Bacteremia
- Cementitious Materials
- Microtubules
- Antibiotic Pharmacokinetics
- FGF21
- Therapy
- Antibiotic Resistance
- Public Health
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Pathogenesis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Epidemiology5▲ 4.7×11 topics
- Antimicrobial Resistance4▲ 68×4 topics
- Cancer3▲ 7.5×7 topics
- Virulence Factors2▲ 57×4 topics
- Metabolism2▲ 15×3 topics
- Healthcare-Associated Infections2▲ 60×2 topics
- Cancer Therapy2▲ 12×4 topics
- Clinical Management2▲ 39×2 topics
- CO2 Sequestration2▲ 35×3 topics
- MRSA2▲ 260×1 topic
- Staphylococcus aureus2▲ 90×1 topic
- Signaling2▲ 106×2 topics
- Bacteremia1▲ 72×2 topics
- Cell Division1▲ 244×1 topic
- Cementitious Materials1▲ 59×1 topic
- Geopolymer1▲ 37×1 topic
- Microtubules1▲ 244×1 topic
- Obesity1▲ 6.6×2 topics
- Antibiotic Pharmacokinetics1▲ 159×1 topic
- Critically Ill Patients1▲ 159×1 topic
- FGF211▲ 398×1 topic
- Fibroblast Growth Factor1▲ 398×1 topic
- Therapy1▲ 24×2 topics
- Tumor Microenvironment1▲ 11×3 topics
- Antibiotic Resistance1▲ 12×4 topics
- HIF-11▲ 76×1 topic
- Public Health1▲ 3.0×3 topics
- Warburg Effect1▲ 76×1 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry1▲ 135×1 topic
- Microorganism Identification1▲ 135×1 topic
- Pathogenesis1▲ 7.9×4 topics
- Mechanical Properties1▲ 3.8×2 topics
Which research topics does Basilea Pharmaceutica (Switzerland) publish most on?
By volume in 2022–2025: Antimicrobial Resistance in Staphylococcus, Concrete and Cement Materials Research, Microtubule and mitosis dynamics and Antibiotics Pharmacokinetics and Efficacy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antimicrobial Resistance in Staphylococcus Infectious Diseases 2 works
- 2 Concrete and Cement Materials Research Civil and Structural Engineering 1 works
- 3 Microtubule and mitosis dynamics Cell Biology 1 works
- 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 1 works
- 5 Fibroblast Growth Factor Research Molecular Biology 1 works
- 6 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 7 Bacterial Identification and Susceptibility Testing Clinical Biochemistry 1 works
- 8 Antifungal resistance and susceptibility Infectious Diseases 1 works
- 9 Innovative concrete reinforcement materials Civil and Structural Engineering 1 works
- 10 Immune cells in cancer Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Basilea Pharmaceutica (Switzerland)'s research output changed?
Output in 2018–2022 was 1% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Basel
- University of Basel
- Novartis (Switzerland)
- University Hospital of Basel
- Roche (Switzerland)
- Swiss Tropical and Public Health Institute
- Multidisciplinary Digital Publishing Institute (Switzerland)
- University Children’s Hospital Basel
- Bank for International Settlements
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.